Medicine & Life Sciences
transglutaminase 2
100%
Breast Neoplasms
24%
Neoplasms
17%
Small Nucleolar RNA
16%
Polymers
16%
Poly(ADP-ribose) Polymerase Inhibitors
15%
Drug Resistance
14%
Adiponectin
12%
NF-kappa B
12%
Doxorubicin
11%
Von Hippel-Lindau Tumor Suppressor Protein
10%
ADP-Ribosylation
9%
nucleophosmin
8%
Ribosomes
8%
Poly (ADP-Ribose) Polymerase-1
8%
Polymerization
8%
RNA Helicases
8%
Cell Line
8%
Glutamine
8%
Adipocytes
7%
Proteostasis
7%
Protein Biosynthesis
7%
Apoptosis Regulatory Proteins
7%
Glucosamine
7%
Calpain
7%
Cell Survival
7%
Gluconeogenesis
7%
Peroxisome Proliferator-Activated Receptors
7%
Triple Negative Breast Neoplasms
7%
Kidney
7%
Renal Cell Carcinoma
7%
Apoptosis
6%
RNA
6%
Proteins
6%
Ubiquitin
6%
Lysine
6%
Pyruvic Acid
6%
Proteasome Endopeptidase Complex
6%
NAD
5%
Knockout Mice
5%
Cystamine
5%
Hypoxia-Inducible Factor 1
5%
Ribosomal DNA
5%
Proteomics
5%
Non-Small Cell Lung Carcinoma
5%
Peptides
5%
Ureteral Obstruction
5%
Chemical Compounds
Lysine Residue
12%
Cell Viability
11%
Adiponectin
10%
Poly(ADPribose)
9%
DAPI
8%
Glutamine Residue
8%
Resistance
7%
Protein
6%
Ablation
6%
Apoptotic
6%
Glutamine
6%
Pyruvate
6%
Fat
5%
Peptide
5%